Main Menu Jump to Page


Retainer Agreement
info@rosenlegal.com

Amneal shareholders have an opportunity to recover their investment losses.

Click "Join This Class Action" above.

Amneal Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) resulting from allegations that Amneal may have issued materially misleading business information to the investing public.

If you purchased Amneal securities and would like to join the action, please click "Join This Class Action," above.

Press Release

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Amneal Pharmaceuticals, Inc. – AMRX

New York, N.Y., July 11, 2019. Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) resulting from allegations that Amneal may have issued materially misleading business information to the investing public.

On July 10, 2019, Amneal cut its 2019 core earnings forecast, citing the uncertain supply of epinephrine auto-injectors amid a global shortage of the emergency allergy shots, including Mylan NV's EpiPen. Amneal also cited delays in regulatory approvals and launches as other reasons for the lowered forecast.

Following this news, shares of Amneal fell $2.45 per share, or 35.98%, to close at $4.36 per share on July 10, 2019.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Amneal investors. If you purchased shares of Amneal please visit the firm’s website at http://www.rosenlegal.com/cases-register-1619.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      cases@rosenlegal.com
      www.rosenlegal.com